Novel Biomaterial Protects Tissues Against Harmful Radiation
|
By MedImaging International staff writers Posted on 23 Jul 2020 |

Image: Human cells treated with Selenomelanin nanoparticles (Photo courtesy of NU)
A synthesized form of melanin enriched with selenium could shield human tissues from X-rays during medical treatment or spaceflight, according to a new study.
Developed at Northwestern University (NU; Evanston, IL, USA), the University of California, San Diego (UCSD; USA), and other institutions, the new material is called Selenomelanin, and is an analogue of pheomelanin (the pigment responsible for red hair, which contains sulfur), that has been shown to absorb X-rays more efficiently than the more common eumelanin, which gives black and brown hair their color. The researchers hypothesized that enriching pheomelanin with selenium instead of sulfur would provide better protection against X-rays.
After synthesizing Selenomelanin, they then used it to treat neonatal human epidermal keratinocytes (NHEK); for comparison, they prepared cells treated with synthetic pheomelanin and eumelanin, as well as cells with no protective melanin at all. All cells were subjected to high-dose X-ray irradiation, at levels that would be lethal to a human being. They found that only those cells treated with Selenomelanin still exhibited a normal cell cycle, and did not undergo G2/M phase arrest. The study was published on July 8, 2020, in the Journal of the American Chemical Society (JACS).
“Melanin may act as a repository for selenium, helping ensure that organisms benefit from it. Our results demonstrated that selenomelanin offers superior protection from radiation,” said senior author Nathan Gianneschi, PhD, of NU. “We also found that it was easier to synthesize selenomelanin than pheomelanin, and what we created was closer than synthetic pheomelanin to the melanin found in nature. Selenomelanin may play an important role in how selenium is metabolized and distributed biologically. It's an area for further investigation.”
Melanins are a family of heterogeneous biopolymers found ubiquitously across plant, animal, bacterial, and fungal kingdoms where they act variously as pigments and as radiation protection agents. There exist five multifunctional, structurally and biosynthetically incompletely understood varieties of melanin: eumelanin, neuromelanin, pyomelanin, allomelanin, and pheomelanin.
Related Links:
Northwestern University
University of California, San Diego
Developed at Northwestern University (NU; Evanston, IL, USA), the University of California, San Diego (UCSD; USA), and other institutions, the new material is called Selenomelanin, and is an analogue of pheomelanin (the pigment responsible for red hair, which contains sulfur), that has been shown to absorb X-rays more efficiently than the more common eumelanin, which gives black and brown hair their color. The researchers hypothesized that enriching pheomelanin with selenium instead of sulfur would provide better protection against X-rays.
After synthesizing Selenomelanin, they then used it to treat neonatal human epidermal keratinocytes (NHEK); for comparison, they prepared cells treated with synthetic pheomelanin and eumelanin, as well as cells with no protective melanin at all. All cells were subjected to high-dose X-ray irradiation, at levels that would be lethal to a human being. They found that only those cells treated with Selenomelanin still exhibited a normal cell cycle, and did not undergo G2/M phase arrest. The study was published on July 8, 2020, in the Journal of the American Chemical Society (JACS).
“Melanin may act as a repository for selenium, helping ensure that organisms benefit from it. Our results demonstrated that selenomelanin offers superior protection from radiation,” said senior author Nathan Gianneschi, PhD, of NU. “We also found that it was easier to synthesize selenomelanin than pheomelanin, and what we created was closer than synthetic pheomelanin to the melanin found in nature. Selenomelanin may play an important role in how selenium is metabolized and distributed biologically. It's an area for further investigation.”
Melanins are a family of heterogeneous biopolymers found ubiquitously across plant, animal, bacterial, and fungal kingdoms where they act variously as pigments and as radiation protection agents. There exist five multifunctional, structurally and biosynthetically incompletely understood varieties of melanin: eumelanin, neuromelanin, pyomelanin, allomelanin, and pheomelanin.
Related Links:
Northwestern University
University of California, San Diego
Latest Nuclear Medicine News
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
Channels
Radiography
view channel
AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
Osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide, is the leading cause of disability among older adults. Current diagnostic tools allow doctors to assess damage... Read more
AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
Cardiovascular disease remains the leading cause of death in women worldwide, responsible for about nine million deaths annually. Despite this burden, symptoms and risk factors are often under-recognized... Read moreMRI
view channel
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read moreUltrasound
view channel
Ultrasound Probe Images Entire Organ in 4D
Disorders of blood microcirculation can have devastating effects, contributing to heart failure, kidney failure, and chronic diseases. However, existing imaging technologies cannot visualize the full network... Read more
Disposable Ultrasound Patch Performs Better Than Existing Devices
Wearable ultrasound devices are widely used in diagnostics, rehabilitation monitoring, and telemedicine, yet most existing models rely on lead-based piezoelectric ceramics that pose health and environmental risks.... Read moreGeneral/Advanced Imaging
view channel
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read morePatient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more







